[Special Edition]: Insurers’ “White Bagging” Drug Policy Threatens Patient Safety

Increases in consolidation and alignment between commercial health plans and pharmacy benefit managers have resulted in a series of business practices designed to steer patients to insurer-affiliated pharmacies and away from patients’ longstanding providers to the detriment of patient care. Under new policies being implemented by a number of large commercial insurance companies, they steer patients to third-party specialty pharmacies – often owned by the same parent company as the insurer – to acquire medication necessary for clinician-administered treatments, such as chemo infusions. Commonly referred to as “white bagging,” this practice raises significant patient safety issues, results in frequent delays in care and shifts tremendous administrative burden to hospitals to reconcile these policies on behalf of their patients. To examine this concerning trend, we hear from Mark Howell, AHA’s director of policy and patient safety, and Michelle Millerick AHA’s senior associate director of health insurance coverage policy.


 

Related Resources

Guides/Reports
Member
What is Paxlovid? Paxlovid (ritonavir-boosted nirmatrelvir) is a preferred oral antiviral authorized for the treatment of mild-moderate COVID-19 illness.…
Special Bulletin
Member
The AHA today released a new report highlighting numerous commercial health insurer policies that compromise patient safety and raise costs.
Advancing Health Podcast
In this podcast, Priya Bathija, vice president of AHA’s strategic initiatives speaks with globally recognized expert and leader in maternal care, Dr. Neel Shah…
AHA Center for Health Innovation Market Scan
CVS Health and Walgreens recently launched clinical trials businesses with an eye toward reducing research costs and making it easier for historically…
Advancing Health Podcast
Dr. Leon D. Caldwell, Senior Director, Health Equity Strategies and Innovation, in the Institute of Diversity and Health Equity at the AHA, sits down with Dr.…
AHA Center for Health Innovation Market Scan
Roundtrip’s continuing development can be traced in part to AWS’ Health Equity Initiative, a three-year $40 million commitment to help its health care…